HIV/AIDS Vaccines
Reports summarize HIV/AIDS vaccines study results from Center for Cancer Research
Published in Vaccine Weekly, November 29th, 2006
Data detailed in "An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains" have been presented. "Although HIV subtype B predominates in North America and Western Europe, most HIV infections worldwide are non-subtype B. Globally effective AIDS vaccines need to elicit broad immunity against multiple HIV strains," scientists in the United States report.
"In this study, 10 chimpanzees were intranasally primed sequentially with adenovirus type 5 (Ad5)-and Ad7-HIVMNenv/rev recombinants and boosted twice intramuscularly with heterologous oligomeric HIVSF162...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-11-29)
More Articles from Vaccine Weekly
- Business Update
Carrington's DelSite subsidiary presents data on needle-free vaccine technology - Business Update
Merck's cervical cancer vaccine Gardasil added to U.S. CDC Vaccines for Children contract - Anthrax Vaccines
Reports summarize anthrax vaccines research from Institute of Infectious Disease - Avian Influenza
Control measures fail to stop spread of new H5N1 virus - Breast Cancer Vaccine
BN ImmunoTherapeutics reports data on breast cancer vaccine shows exceptional efficacy - Business & Finance
Carrington reports 18% revenue increase in third quarter - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
